Development Aid: Tuberculosis

(asked on 24th January 2022) - View Source

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for the Foreign, Commonwealth and Development Affairs, whether her Department has made an assessment of the impact of the recent reductions in Official Development Assistance on diagnostics, treatments and services for TB.


Answered by
Amanda Milling Portrait
Amanda Milling
Government Whip, Lord Commissioner of HM Treasury
This question was answered on 27th January 2022

The World Health Organisation's 2021 Global Tuberculosis Report provided an assessment of progress on TB in 2020. The report notes an 18% decline since 2019 in the reported number of people newly diagnosed with TB and a decline in TB treatment coverage from 72% in 2019 to 59% in 2020. The report attributes this to disruption caused by the COVID-19 pandemic and a fall in global spending on TB diagnostic, treatment and prevention services from $5.8 billion to $5.3 billion.

The majority of FCDO's funding to diagnostics, treatments and services for TB is through our investment in the Global Fund to Fight AIDS, Tuberculosis and Malaria. The UK remains the second largest donor to the sixth replenishment (2020-2022) with a pledge of up to £1.4 billion. We also invest in TB research and innovation, to help people access new TB treatments and diagnostics, and to provide evidence on best practices to tackle the disease.

Reticulating Splines